Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on Shield Therapeutics Plc. We currently have 436 research reports from 9 professional analysts.
- Open: 1.48p
- Range Today: 1.45/1.49p
- 52 Week: 1.45/12.8p
- Daily Volume: 332.0k
- Daily Liquidity: 0.04%
- # Shares: 782.1m
- Market Cap: £11.5m
- Latest PE (hist):
- Div Yield:
Date | Source | Announcement |
---|---|---|
16Apr24 07:00 | RNS | Shield Therapeutics - Notice of Results |
21Feb24 07:00 | RNS | Shield Therapeutics - Unaudited Full Year Trading Update |
09Jan24 07:00 | RNS | Shield Therapeutics - Appointment of new Chief Financial Officer |
07Dec23 07:00 | RNS | Shield Therapeutics - Q3 2023 U.S. Commercial Highlights |
27Nov23 17:24 | RNS | Shield Therapeutics - PDMR Transaction Notification |
15Nov23 07:30 | DGAP-News | Hardman & Co Research on Shield Therapeutics (STX): Accelerating effectiveness of enlarged sales team |
20Oct23 11:45 | RNS | Shield Therapeutics - Abstract to be presented at Healthcare Conference |
Share: